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Abstract  
AIM: To assess the associations between the body adiposity indices and risk of metabolic 
syndrome (MS) and its components in Egyptian women and to evaluate their predictive power. 
MATERIALS AND METHODS: This was a cross-sectional analysis performed on 180 Egyptian 
women aged between 25-35 years. They were 90 women with MS diagnosed by International 
Diabetes Federation (IDF) and 90 healthy age matched controls. Body adiposity index (BAI), body 
mass index (BMI), waist to hip ratio (WHR) and waist to height ratio (WHtR) were calculated and 
serum samples were analyzed for metabolic parameters. Receiver operating characteristic curves 
(ROC) was used to determine the discriminatory capacity of BAI, WHR WHtR and BMI for MS. 
RESULTS: Area under the curve (AUC) was highest for BIA, followed by WHR, WHtR and then 
BMI. All adiposity indices were significantly correlated with metabolic components and BAI had the 
highest correlation coefficients compared to other indices. 
CONCLUSION: BAI is a practical predictor for MS and has satisfactory diagnostic accuracy for 
diagnosing MS among Egyptian women and can be used in addition to WHR, WHtR and BMI for 
identifying MS in the field studies. 
 
 
 
 
Introduction 
 
Obesity has become one of the most 
important public health problems. The increase in 
prevalence of obesity involves an increase in the 
prevalence of several obesity-related diseases [1–3]. 
Several studies show the relation between th e 
adipose tissue accumulation and the incidence of 
adverse metabolic events and, also, with a higher risk 
for developing metabolic diseases [4-10]. The 
metabolic syndrome (MS) is a set of interrelated risk 
factors such as hypertension, dyslipidemia, obesity 
and high blood glucose. 
Insulin resistance together with 
central/abdominal or visceral obesity has been 
proposed as the key factors in the development of the 
MS. Several authors have tested the correlations 
between the indices of adiposity and several health 
outcomes [11-13]. There is no universally agreed 
definition for MS. Despite the use of the same index 
for central obesity assessment, the National 
Cholesterol Education Program (NCEP) Adult 
Treatment Panel III (ATP III) [14] and International 
Diabetes Federation (IDF) [15] differed in the waist 
circumference (WC) cut-off points. ATPIII proposed 
WC more than or equals 88 cm for women, whereas 
IDF proposed WC cut-off points based on population 
estimates. Body mass index (BMI), WC, and waist to 
hip ratio has all been tested for their relation to MS, 
but with no consistent results across the globe. The 
prevalence also varies by ethnicity. In the National 
Health and Nutrition Examination Survey III (NHANES 
III) [16], the age-adjusted prevalence was 30–
40%higher in p eople of Mexican–American origin 
than in persons of White and African–American origin.  
The highest prevalence is found in the Middle 
East region, where more than every third person 
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above the age of 20 fulfils the criteria for having the 
metabolic syndrome. The syndrome is common and 
has a rising prevalence worldwide, relating largely to a 
complex interplay of rapid nutritional alterations, 
sedentary lifestyle and socioeconomic evolution, 
increasing affluence, rural-to urban migration, leading 
to obesity. 
This study aims to evaluate the predictive 
power of adiposity indices as predictors for MS in the 
sample of Egyptian women. 
 
 
Material and Methods 
 
The present cross-sectional study was carried 
out on 90 obese Egyptian women (aged 25-35 years 
old) recruited from obesity clinic National Research 
Centre with MS having the presence of 3 or more 
criteria/parameters according to the International 
Diabetes Federation (IDF) and 90 healthy controls 
without or even have a single parameter of metabolic 
syndrome. A written informed consent was obtained 
from each study subject. 
IDF criteria are: central obesity (defined as 
waist circumference >80 cm). If BMI is > 30 kg/m
2
, 
central obesity can be assumed and waist 
circumference does not need to be measured, BMI 
has no relation with central obesity measured by WC, 
as there are some bodies have BMI > 30 Kg/m and 
WC less than 88 cm, triglycerides >150 mg/dL or 
specific treatment for this lipid abnormality, HDL-
cholesterol < 50 mg/dL and blood pressure >130/85 
mmHg or treatment of previously diagnosed 
hypertension, fasting plasma glucose >100 mg/dL or 
previously diagnosed type 2 diabetes. When central 
obesity plus two of the four previous criteria are met, a 
diagnosis of metabolic syndrome can be made [17]. 
BMI was calculated as weight (kg) divided by height 
(m) squared (kg/m
2
). BAI was calculated using the 
equation ((hip circumference)/((height) 1.5)-18) [18]. 
WC and hip circumference (HC) were 
measured using inelastic tape at the level midway 
between the lateral lower rib margin and iliac crest as 
well as at the levels of trochanters. WHR was 
calculated as WC divided by HC and WHtR was 
calculated as WC divided by height in centimeters. 
 
Serum analysis 
Blood samples were collected after a 12-h 
overnight fast and stored at < 80°C until analyzed. An 
Olympus AU400 automatic analyzer (Olympus 
Corporation, Tokyo, Japan) was used to measure 
serum total cholesterol (TC), High Density Lipoprotein 
cholesterol (HDL-C), triglycerides (TG) and low 
Density Lipoprotein cholesterol (LDL-C) was 
calculated. Fasting blood glucose (FBG) was 
measured with commercial kits (Roche Diagnostics, 
Indianapolis, IN, USA) and fasting blood insulin (FBI) 
were determined with the Phadebas Insulin Test 
(Pharmacia, Uppsala, Sweden) using a 
radioimmunosorbent technique. The insulin sensitivity 
was then calculated using Homeostasis Model 
Assessment (HOMA-IR) according to the following 
formula: HOMA-IR = FBG (mmol/L) ×FBI 
(μU/ml)/22.5. 
Table 1: Age, anthropometric, clinical and biochemical indices 
characteristics of the study participants 
Characteristics MS Non-MS 
Age 28.42 ± 2.45 29.42 ± 3.56 
BMI (kg/m
2
) 30.42 ± 3.70 23.51 ± 2.91 *** 
Waist circumference (cm) 106.42 ± 10.00 99.46 ± 17.395 *** 
Hip circumference (cm) 125.22 ± 12.89 119.01 ± 10.78 *** 
WHR 0.89 ± 0.05 0.80 ± 0.13 *** 
WHtR 0.72 ± 0.01 0.59 ± 0.01 *** 
BAI (kg/m
2
) 35.75 ± 4.22 25.65 ± 3.31 *** 
Systolic BP (mmHg 120.00 ± 12.6 115.71 ± 18.44 *** 
Diastolic BP (mmHg) 94.54 ± 6.87 73.83 ± 10.43 *** 
FBG (mg/dl) 112.52 ± 8. 22 90.52 ± 5.22 *** 
FBI (μU/ml) 18.20 ± 0.85 8.20  ± 0.65 *** 
HOMA-IR 6.88 ± 1.29 2.3 ± .99 *** 
Triglycerides (mg/dl) 145.65 ± 30.61 100.41 ± 33.29 *** 
Total cholesterol (mg/ dl) 174.71 ± 30.81 124.71 ±  23.81 *** 
LDL-C (mg/dl) 163.71 ± 35.890 112.61 ± 29.381 *** 
HDL-C (mg/dl) 45.44 ± 15.217 47.86 ± 14.560 *** 
BMI: body mass index; WHR: waist to hip ratio; WHtR: waist to height ratio; BAI: body 
adiposity Index; FBG: fasting blood glucose; FBI: fasting blood insulin; HOMA-IR: 
homeostasis model assessment of Insulin Resistance; HDL-C: high-density lipoprotein 
cholesterol; LDL-C: low-density lipoprotein cholesterol. *** Significant at p-value < 0.001.  
 
 
Statistical Analyses 
All the data were tested for their normal 
distribution (Kolmogorov–Smirnov test). Results are 
expressed as means and standard deviations (SD). 
Student t test for unpaired data was used to evaluate 
differences in anthropometric and biochemical 
characteristics between cases and controls. 
The existence of significant bivariate 
correlations between parameters such as BAI, BMI, 
WHR, WHtR and biochemical parameters and 
metabolic risk factors was ascertained by determining 
correlation coefficients. Receiver operating 
characteristic curves were used to determine 
discriminatory capacity of BAI, WHR, WHtR and BMI 
for metabolic syndrome risk. 
Statistical analysis was carried out using IBM 
SPSS Statistics 20.0 software (SPSS/IBM, Chicago, 
IL, USA). Significance was accepted at p<0.05. 
 
 
Results 
 
Table1 shows clinical, biochemical and 
anthropometric characteristics of the study 
participants. Statistically significant differences were 
found between the MS cases and controls in all 
anthropometric and biochemical parameters. Women 
with MS showed significant higher values of BMI, WC, 
HC, WHR, WHtR, BAI, blood pressure levels, LDL-C, 
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TG, FBI, FBG, HOMA-IR and lower HDL-C than 
normal controls (p < 0.001). 
 
Figure 1: ROC Curve to determine the diagnostic value of body 
adiposity indices to predict the metabolic Syndrome 
 
 
Figure 1 shows the ROC curve for BAI,BMI 
and WHR with respect to the presence of MS. Area 
Under the Curve(AUC) was 69.8% (95% CI: 62.2% – 
81. 3%) for BIA, 67.3% (95% CI:56.8% – 80.9%) for 
WHR,65.9% (95% CI:56.8% –79.9%)for WHtR and 
61.3% (95% CI: 48.2%-78.5%) for BMI. BAI showed 
higher discriminatory capacity than WHR, WHtR and 
BMI for MS risk.  
Table 2: Partial correlations between adjusted body adiposity 
indices and metabolic components; to exclude the effect of 
age 
 BAI WHR WHtR BMI 
Systolic BP 0.727
** 
0.560
** 
0.461
** 
0.361
* 
Diastolic BP 0.686
** 
0.502
** 
0.434
** 
0.374
** 
FBG 0.586
*** 
0.3214
** 
0.294
* 
0.283
* 
FBI 0.575
*** 
0.402
** 
0.382
* 
0.361
* 
HOMA-IR 0.486
** 
0.482
** 
0.464
** 
0.253
* 
Triglyceride 0.485
** 
0.404
** 
0.384
* 
0.251
* 
HDL-C -0.583
** 
-0.455
** 
-0.335
* 
-0.237
* 
LDL-C 0.486
*** 
0.381
** 
0.335
* 
0.235
* 
 
Table 2 shows the coefficients of partial 
correlation between anthropometric measures and 
metabolic risk factors. BAI had the highest correlation 
coefficients with metabolic components followed by 
WHR and WHtR and then BMI. 
 
 
Discussion 
 
The objective of this cross sectional study 
was to analyze correlation of body adiposity indices 
with metabolic risk factors among Egyptian women 
aged 25-35 years old. Adipose tissue accumulation 
increases the incidence and risk of adverse metabolic 
events and diseases. 
To our knowledge this study is the first study 
focused on evaluating the applicability of BAI as a 
method to determine metabolic risk in a sample of 
Egyptian women and determine the validity of each of 
BAI, WHR, WHtR and BMI that might have predictive 
power for the risk of MS. The main finding of the 
present study is that BAI a good adiposity predictor for 
MS and overcome the limitations of BMI and the other 
indices analyzed. Body fat content, fat distribution or 
adiposity, therefore, could be considered as important 
indicators of metabolic risk. Body adiposity index has 
been developed, to overcome the shortcomings of 
BMI and it can be used to reflect body fat percentage 
(BF %) in adults [19, 20]. BAI was suggested to have 
several advantages over BMI, including that it yields 
similar associations with BF% for men and women 
and may be more practical to assess in field studies 
because it does not require a weight measurement 
and it can be used to reflect body fat percentage (BF 
%) in adults. It has been suggested that the BAI can 
be used to mirror %body fat for adult men and women 
of differing ethnicities without numerical correction. 
BAI was suggested to have several 
advantages over BMI, including that it yields similar 
associations with BF% for men and women and may 
be more practical to assess in field studies because it 
does not require a weight measurement [21]. 
Current study tested adiposity indices for 
identifying MS using ROC curves and detect their 
sensitivity and specificity in the categorization of MS 
among Egyptian women. 
The present results demonstrated that BAI 
has the higher discriminatory capacity (higher area 
under the curve) than the WHR, WHtR and BMI from 
ROC curves for identifying MS (IDF criteria). Area 
Under the Curve (AUC) was 69.8% for BIA, 67.3% for 
WHR,65.9% for WHtR and 61.3% for BMI, indicating 
that BMI has the weakest predictive power as 
compared to other adiposity indices. Moreover, partial 
correlation analysis showed that BAI had the highest 
correlation with metabolic risk factors compared to 
other adiposity indices. BAI level in subjects with 
metabolic syndrome was 35.75 ± 4.22 and 25.65 ± 
3.31 in healthy controls. 
The syndrome is common and has a rising 
prevalence worldwide, relating largely to a complex 
interplay of rapid nutritional alterations, sedentary 
lifestyle and socioeconomic evolution, increasing 
affluence, rural -tourban migration, leading to obesity 
[22]. 
However other studies reported that BAI could 
be less useful than BMI when the metabolic health 
risk is evaluated. Furthermore, this study suggested 
that WC and WHR may be even better candidates 
than BMI or BAI as simple (only tape measurements 
are required) and practical indicators of cardiovascular 
health risk [23]. 
In the IDF definition for MS, central obesity 
(increased WC) is a pre-requisite criterion in addition 
to two or more of the other major risk factors. The IDF 
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definition was adopted in this study for identifying 
subjects with MS and studying the relation between 
different risk factors. Different measures of central 
obesity have been developed over time including 
WHR, BMI, WC, and WHtR [22-24]. The first definition 
of MS by World Health Organization (WHO) used BMI 
and WHR. The ATPIII used BMI and WC to indicate 
central obesity, whereas the IDF only used WC in 
their MS criteria. 
Our study showed significant partial 
correlations between adiposity indices and metabolic 
syndrome risk factors after controlling for age with 
highest correlations BAI followed by WHR then WHtR 
and BMI. In agreement to the current study, several 
studies have shown that the BAI supposes a new 
approach in order to determine the adiposity and MS 
[19-24]. 
WHtR ratio may reflect visceral fat more 
accurately than WHR, since the latter indicator does 
not reflect visceral fat properly as it may stay the 
same because WC and hip circumference can 
increase or decrease proportionately. However, 
previous study from Iran demonstrated that increased 
WHR was a better predictor for CVD risk factors than 
BMI, WC and WHtR, in all age groups [25]. BAI has 
been suggested to have several advantages over 
BMI. BAI gives similar associations with BF% for men 
and women and may be more practical to assess in 
field studies because it does not require a weight 
measurement. Many techniques have been developed 
for assessing and/or determining body fat or adiposity. 
These include the BMI, WC, WHtR, skinfold thickness, 
dual energy X-ray absorption (DXA) and hydrostatic 
densitometry [22-26]. 
In our study, BMI, BAI were and WHR were 
significantly correlated with metabolic parameters; 
correlations of BAI were stronger than WHR and BMI. 
ROC analysis revealed also superior discrimination of 
BAI compared to BMI and WHR. 
A recent study done in north India concluded 
that the correlation of BMI to percentage of body fat 
was better than that of BAI to percentage of body fat, 
the sensitivity and specificity of BAI were similar to, if 
not better than, BMI [27, 28] . 
The BAI can be measured without weighing, 
which renders it BAI was developed and validated in 
studies of Mexican American and African-American 
adults. Several studies of BAI values for predicting fat 
content or metabolic disorders in European-American, 
Mexican-American, Caucasian and Asian subjects 
have reported controversial results [29-31]. In 
Caucasians, BAI is a better estimate of adiposity than 
BMI in non-obese subjects, but less effectively than 
BMI in obese men and women. Another study 
reported that BMI more strongly correlated with BF% 
than BAI, and more highly associated with diabetes 
risk in Caucasian [32]. BMI was more accurate 
surrogate for adiposity in American [33, 34], Mexican 
Americans [35] Caucasian [36, 37] and Asian subjects 
[38]. Lifestyles have been changed over the preceding 
decades in developing countries, especially in Egypt. 
Increase in sedentary lifestyles has been observed 
that likely contribute to an increased incidence of MS 
[39]. Moreover, MS and its components (high waist 
circumference, high triglyceride levels, and low high 
density lipoprotein cholesterol levels) were 
significantly associated with menstrual irregularity in 
women of reproductive age [40]. 
In conclusion, BAI is practical predictor for MS 
and has a significant diagnostic accuracy for 
diagnosing MS among Egyptian women and can be 
used as a useful predictor in addition to other 
adiposity indices (WHR, WHtR and BMI) for 
identifying MS in the field studies. 
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